SCHEMBL16331586

SCHEMBL16331586

CNc1nc2cnc(Nc3cccc(F)c3)cc2n1Cc1ccc(OC)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ BRAF P15056 1/20 0.42
▸ LMNA P02545 3/20 0.42
▸ ABCG2 Q9UNQ0 1/20 0.41
▸ CSF1R P07333 3/20 0.41
▸ EGFR P00533 3/20 0.41
▸ ERBB2 P04626 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ CASP7 P55210 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ LCK P06239 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16332395 0.90 LMNA (0.47) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2D6
SCHEMBL16332494 0.90 LMNA (0.47) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2D6
SCHEMBL16332134 0.90 SMN1; SMN2 (0.52) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2D6
SCHEMBL16331960 0.90 CSF1R (0.46) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2D6
SCHEMBL16332658 0.89 PDGFRB (0.50) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2D6
SCHEMBL16332121 0.86 EGFR (0.44) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2D6
SCHEMBL16332069 0.86 CYP1A2 (0.41) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2D6
SCHEMBL16332223 0.85 SMN1; SMN2 (0.44) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2D6
SCHEMBL16332551 0.84 SMN1; SMN2 (0.43) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2D6
SCHEMBL16331531 0.83 CSF1R (0.47) SMN1; SMN2CYP1A2CYP3A4CYP2C9CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2818472-A1 Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — EP claimed
EP-2818472-A1 Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-12-31 — — EP disclosed
Send feedback